Summary
We report very large hepatic peroxisomes (d-circle >1 Μm) in a patient with rhizomelic chondrodysplasia punctata and a patient with acyl-CoA oxidase deficiency. The effects of peroxisomal enlargement on the enzymatic activity are discussed. As increase in peroxisomal size is also reported in at least 12 other patients with peroxisomal disorders, we propose, a relationship between the enlargement of the organelles and their functional deficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boles DJ, Craft DA, Padgett DA, Loria RM, Rizzo WB (1991) Clinical variations in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts. Biochem Med Metab Biol 45:74–91
Christiansen EN, Flatmark T, Kryvi H (1981) Effects of marine oil diet on peroxisomes and mitochondria of rat liver. A combined biochemical and morphometric study. Eur J Cell Biol 26:11–20
De Craemer D, Kerckaert I, Roels F (1991) Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: a quantitative study. Hepatology (in press)
Espeel M, Roels F, De Craemer D, Van Maldergem L, Dacremont G, Wanders RJA, Hashimoto T (1991) Peroxisomal localization of the immunoreactiveΒ-oxidation enzymes in a neonate with aΒ-oxidation defect. Pathological observations in liver, adrenal cortex and kidney. Virchows Arch [A] (in press)
Fringes B, Reith A (1982) Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism. Lab Invest 47:19–26
Heymans HSA, Oorthuys JWE, Nelck G, Wanders RJA, Dingemans KP, Schutgens RBH (1986) Peroxisomal abnormalities in rhizomelic chondrodysplasia punctata. J Inherited Metab Dis 9 [Suppl 2]:329–331
Hughes JL, Poulos A, Robertson E, Chow CW, Sheffield LJ, Christodoulou J, Carter RF (1990) Pathology of hepatic peroxisomes and mitochondria with peroxisomal disorders. Virchows Arch [A] 416:255–264
Kerckaert I, Claeys A, Just W, Cornelis A, Roels F (1989) Automated image analysis of rat liver peroxisomes after treatment with thyroid hormones: changes in number, size and catalase reaction. Micron Microsc Acta 20:9–18
Kyllerman M, Blomstrand S, Mansson JE, Conradi NG, Hindmarsh T (1990) Central nervous system malformations and white matter changes in pseudo-neonatal adrenoleukodystrophy. Neuropediatrics 21:199–201
Naidu S, Hoefler G, Watkins PA, Chen WW, Moser AB, Hoefler S, Rance NE, Powers JM, Beard M, Grcen WR, Hashimoto T, Moser HW (1988) Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy. Neurology 38:1100–1107
Poll-The BT, Roels F, Ogier H, Scotto J, Vamecq J, Schutgens RBH, Wanders RJA, van Roermund CWT, van Wijland MJA, Schram AW, Tager JM, Saudubray JM (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukocystrophy). Am J Hum Genet 42:422–434
Poulos A, Sheffield L, Sharp P, Sherwood G, Johnson D, Beckman K, Fellenberg AJ, Wraith JE, Chow CW, Usher S, Singh H (1988) Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients. J Pediatr 113:685–690
Roels F (1991) Peroxisomes, a personal account. VUB Press, Brussels
Roels F, Cornelis A (1989) Heterogenetiy of catalase staining in human hepatocellular peroxisomes. J Histochem Cytochem 37:331–337
Roels F, Verdonck V, Pauwels M, De Catte L, Lissens W, Liebaers I, Elleder M (1987) Light microscopic visualization of peroxisomes and plasmalogens in first trimester chorionic villi. Prenat Diagn 7:525–530
Roels F, Pauwels M, Poll-The BT, Scotto J, Ogier H, Aubourg P, Saudubray JM (1988) Hepatic peroxisomes in adrenoleukodystrophy and related syndromes: cytochemical and morphometric data. Virchows Arch [A] 413:275–285
Roels F, Espeel M, De Craemer D (1991) Liver pathology and immunocytochemistry in congenital peroxisomal diseases. J Inherited Metab Dis (in press)
Sherratt HSA, Bartlett K, Bone AJ, Koundakjian PP, Turnbull DM, Osmundsen H, Van Hoof F (1982) Hepatic peroxisomal proliferation caused by ethyl-2(5(4-chlorophenyl)pentyl)oxiran-2-carboxylate (CPOC): a hypoglycemie inhibitor of mitochondrial fatty acid oxidation. Ann NY Acad Sci 386:446–448
Veitch K, Draye JP, Vamecq J, Causey AG, Bartlett K, Sherratt HSA, Van Hoof F (1989) Altered acyl-CoA metabolism in riboflavin deficiency. Biochim Biophys Acta 1006:335–343
Wanders RJA, Schutgens RBH, Heymans HSA, Collins J, Goldfischer S, Hashimoto T, Schrakamp G, van den Bosch H, Tager JM, Schram AW (1987) Biochemical analysis in peroxisomal disorders. In: Fahimi HD, Sies H (eds) Peroxisomes in biology and medicine. Springer, Berlin Heidelberg New York, pp 341–352
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Craemer, D., Zweens, M.J., Lyonnet, S. et al. Very large peroxisomes in distinct peroxisomal disorders (rhizomelic chondrodysplasia punctata and acyl-CoA oxidase deficiency): novel data. Vichows Archiv A Pathol Anat 419, 523–525 (1991). https://doi.org/10.1007/BF01650683
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01650683